Clinical trial
The Nucleus Hybrid L24 Implant System: Extended Duration Post Approval Study
NCT02379273 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Nucleus Hybrid L24 Implant System: Extended Duration Post Approval Study
- Lead sponsor
- Cochlear
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 14, 2015
- Completion date
- March 18, 2019
- Enrollment
- 35 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.